John M. Thorp Jr., MD 
Hugh McAllister Distinguished Professor
of Obstetrics & Gynecology.
Interim Director, Division of Women’s
Primary Healthcare.

Phone: (919) 843-7850
Fax: (919) 966-6001
E-Mail: john_thorp@med.unc.edu
Mailing Address: CB #7570, UNC-Chapel Hill
Chapel Hill, NC 27599-7570

Recent Honors
• Hugh McAllister Distinguished Professorship in
--Obstetrics & Gynecology, 2001-Present
• Professor Teaching Award 1993, 2000,
--Department of Obstetrics & Gynecology
--School of Medicine, University North Carolina
--at Chapel Hill
• Perinatal Health Model of Excellence, 1999
--North Carolina Department of Health & Human
--Services in Conjunction with the March of Dimes
• North Carolina Division of Mental Health, 1999
--Developmental Disabilities and Substance
--Abuse Services Recognition Award for
--Outstanding Service to Women and Children

Education
B.A. Zoology:
University of North Carolina at Chapel Hill, 1975-1979

Doctor of Medicine:
East Carolina University School of Medicine, 1979-1983

Residency
University of North Carolina School of Medicine 
Obstetrics and Gynecology, 1983-1986   
Chief Administrative Resident, 1986-1987

Fellowship
University of North Carolina School of Medicine 
Division of Maternal-Fetal Medicine, 1987-1989

Board Certifications
Obstetrics and Gynecology
Maternal-Fetal Medicine

Professional Societies
• Vice President, Southern Obstetrics
--& Gynecologic Society, 2003
• South Atlantic Association of Obstetrics
--& Gynecology, 1994
• Society for Gynecologic Investigation, 1993
• Association of Professors of Obstetrics
--& Gynecology, 1993
• Society for Maternal-Fetal Medicine, 1984
• American College of Obstetricians
--& Gynecologists, 1983

Committee Assignment
• University of North Carolina at Chapel Hill,
--Promotion Committee, Chapel Hill, NC
--July 2003 – June 2005
• National Institute of Health, July 2003 – June 2006
• Obstetrics & Maternal-Fetal Biology Subcommittee
• National Institue of Child Health and Human --Development

Clinical Interests
• Preterm Delivery
• Pelvic Floor Dysfunction
• Perinatal Substance Abuse

Recent Publications
Lukes AG, Thorp JM, Jr., Eucker B.  Predictors of positivity forfetal fibronectin in patients with symptoms of preterm labor.  Am J ob/Gyn, 176:639-41, 1997.

Wright L, Thorp JM, Jr., Hartmann K.  Transdermal nicotine replacement in pregnancy:  Maternal pharmocokinetics and fetal effects.  Am J Ob/Gyn, 176:1090-4, 1997.

Peaceman AM, Andrews WW, Lukes AG, et al.  Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.  Am J. Ob/Gyn, 177:13-8, 1997.

Savitz DA, Ananth CV, Luther ER, Thorp JM, Jr.  Influence of Gestational Age on the Time from Spontaneous Rupture of the Chorioamniotic Membranes to the Onset of Labor.  Am J. Perinat 1997; 14:129-33.

Wright LN, Thorp JM, Jr., Kuller JA Shrewsbury RP, Ananth C, Hartman K.  Transdermal nicotine replacement in pregnancy:  Maternal pharmacokinetics and fetal effects.  Am J Obstet Gynecol  1997;176:090-4.

Archer DF, Maheus R, DelConte A et al.  A NewLow-Dose Monophasic Combination Oral Contraceptive (Alesseä) with Levonorgestrel 100mg and Ethinyl Estradiol 20 mg.  North American Levonorgestrel Study.  Contraception 55:139-44, 1997.